midkine antisense oligonucleotide (Roquefort Therpaeutics/Lyramid/Murdoch university)

N/A

Report date: 2025/03/20 15:23:42
NME

Base Information

Drug Namemidkine antisense oligonucleotide (Roquefort Therpaeutics/Lyramid/Murdoch university)
Drug Alias Namesplice-switching antisense oligonucleotide targeting midkine (Roquefort Therpaeutics/Lyramid/Murdoch university)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMidkine modulators
TargetsMidkine
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMurdoch University
China Registration ClassN/A

Develop Information

Active CompaniesMurdoch UniversityLyramid LtdRoquefort Therapeutics plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A